Finance

Lists
600488:SHA
Jinyao Pharmaceutical Co Ltd
CNÂ¥4.92
+1.86%
(+0.090) 1D
Nov 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600488...
Open
CNÂ¥4.80
High
CNÂ¥4.94
Low
CNÂ¥4.73
Mkt. cap
5.27B
Avg. vol.
88.36M
Volume
51.05M
Dividend
1.06%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 14, 2026
P/E ratio
114.98
52-wk high
CNÂ¥8.44
52-wk low
CNÂ¥3.68
EPS
CNÂ¥0.04
Shares outstanding
1.09B
No. of employees
3K
Open
CNÂ¥4.80
High
CNÂ¥4.94
Low
CNÂ¥4.73
Mkt. cap
5.27B
Avg. vol.
88.36M
Volume
51.05M
Dividend
1.06%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 14, 2026
P/E ratio
114.98
52-wk high
CNÂ¥8.44
52-wk low
CNÂ¥3.68
EPS
CNÂ¥0.04
Shares outstanding
1.09B
No. of employees
3K
News stories
From web sources and news partners
About Jinyao Pharmaceutical Co Ltd
CEO-
Employees2.73K
Founded1939
Headquarters-
SectorPharmaceutical industry
Industry-
Websitekingyork.biz
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
676.50M
608.11M
704.94M
551.15M
Cost of goods sold
483.21M
352.88M
476.57M
314.63M
Cost of revenue
483.21M
352.88M
476.57M
314.63M
Research and development expenses
38.57M
22.32M
24.78M
28.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.11M
177.46M
169.79M
139.03M
Operating expense
232.54M
202.12M
197.72M
174.00M
Total operating expenses
715.75M
554.99M
674.29M
488.63M
Operating income
-39.25M
53.12M
30.65M
62.53M
Other non operating income
69.08M
-4.08M
3.56M
-12.95M
EBT including unusual items
-6.06M
21.61M
45.72M
15.69M
EBT excluding unusual items
21.61M
45.73M
21.85M
55.79M
Income tax expense
-15.82M
6.36M
9.57M
3.85M
Effective tax rate
261.02%
29.41%
20.92%
24.54%
Other operating expenses
7.48M
1.44M
3.31M
6.38M
Net income
1.02M
13.89M
29.28M
2.53M
Net profit margin
0.15%
2.28%
4.15%
0.46%
Earnings per share
-
-
-
-
Interest and investment income
507.17K
1.34M
593.39K
2.16M
Interest expense
-5.14M
-4.84M
-4.79M
-3.91M
Net interest expenses
-4.63M
-3.50M
-4.20M
-1.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
33.12M
125.49M
100.45M
134.89M
Gain or loss from assets sale
-404.02K
-
417.62K
-417.62K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps